579
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Analysis of the inhibition potential of zosuquidar derivatives on selected bacterial and fungal ABC transporters

, , , , , & show all
Pages 217-227 | Received 31 Mar 2012, Accepted 09 Sep 2012, Published online: 28 Jan 2013

References

  • Balakrishnan L, Venter H, Shilling RA, Van Veen HW. 2004. Reversible transport by the ATP-binding cassette multidrug export pump LmrA: ATP synthesis at the expense of downhill ethidium uptake. J Biol Chem 279:11273–11280.
  • Baykov AA, Evtushenko OA, Avaeva SM. 1988. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem 171:266–270.
  • Conseil G, Decottignies A, Jault JM, Comte G, Barron D, Goffeau A, 2000. Prenyl-flavonoids as potent inhibitors of the Pdr5p multidrug ABC transporter from Saccharomyces cerevisiae. Biochemistry 39:6910–6917.
  • Conseil G, Perez-Victoria JM, Renoir JM, Goffeau A, Di Pietro A. 2003. Potent competitive inhibition of drug binding to the Saccharomyces cerevisiae ABC exporter Pdr5p by the hydrophobic estradiol-derivative RU49953. Biochim Biophys Acta 1614:131–134.
  • Dantzig AH, Law KL, Cao J, Starling JJ. 2001. Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic. Curr Med Chem 8:39–50.
  • Dittrich T, Hanekop N, Infed N, Schmitt L, Braun M. 2012. Synthesis of 5-oxyquinoline derivatives for reversal multidrug resistance. Beilstein J. Org. Chem 8:1700–1704.
  • Egner R, Rosenthal FE, Kralli A, Sanglard D, Kuchler K. 1998. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. Mol Biol Cell 9:523–543.
  • Ernst R, Kueppers P, Klein CM, Schwarzmueller T, Kuchler K, Schmitt L. 2008. A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5. Proc Natl Acad Sci USA 105:5069–5074.
  • Fukazawa N, Odate M, Suzuki T, Otsuka K, Tsuruo T, Sato W. 1990. Preparation of heterocyclic compounds as anticancer drug potentiators. EP 363212.
  • Fukazawa N, Suzuki T, Otsuka K, Yano O, Sato W, Tsuruo T. 1992. New quinolines, their preparations, and anticancer activity enhancers containing the quinolines. Japanese patent 04235983.
  • Golin J, Ambudkar SV, Gottesman MM, Habib AD, Sczepanski J, Ziccardi W, 2003. Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux. J Biol Chem 278:5963–5869.
  • Gottesman MM, Fojo T, Bates SE. 2002. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2:48–58.
  • Heller DP, Greenstock CL. 1994. Fluorescence lifetime analysis of DNA intercalated ethidium bromide and quenching by free dye. Biophys Chem 50:305–312.
  • Kolaczkowski M, Van Der Rest M, Cybularz-Kolaczkowska A, Soumillion JP, Konings WN, Goffeau A. 1996. Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J Biol Chem 271:31543–31548.
  • Lubelski J, De Jong A, Van Merkerk R, Agustiandari H, Kuipers OP, Kok J, 2006a. LmrCD is a major multidrug resistance transporter in Lactococcus lactis. Mol Microbiol 61:771–781.
  • Lubelski J, Konings WN, Driessen AJ. 2007. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol Mol Biol Rev 71:463–476.
  • Lubelski J, Mazurkiewicz P, Van Merkerk R, Konings WN, Driessen AJ. 2004. ydaG and ydbA of Lactococcus lactis encode a heterodimeric ATP-binding cassette-type multidrug transporter. J Biol Chem 279:34449–34455.
  • Lubelski J, Van Merkerk R, Konings WN, Driessen AJ. 2006b. Nucleotide-binding sites of the heterodimeric LmrCD ABC-multidrug transporter of Lactococcus lactis are asymmetric. Biochemistry 45:648–656.
  • Morschhauser J. 2010. Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol 47:94–106.
  • Pfister JR, Lynne SD. 1994. 10,11-Methanodibenzosuberane derivatives used as chemosensitizing agents.
  • Pfister JR, Makra F, Muehldorf AV, Wu H, Nelson JT, Cheung P, 1995. Methanodibenzosuberylpiperazines as potent multidrug-resistance reversal agents. Bioorgan Medic Chem Lett 5:2473–2476.
  • Piddock LJ. 2006a. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19:382–402.
  • Piddock LJ. 2006b. Multidrug-resistance efflux pumps – not just for resistance. Nat Rev Microbiol 4:629–636.
  • Prasad R, De Wergifosse P, Goffeau A, Balzi E. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27:320–329.
  • Sanglard D, Coste A, Ferrari S. 2009. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9:1029–1050.
  • Shapiro AB, Ling V. 1995. Reconstitution of drug transport by purified P-glycoprotein. J Biol Chem 270:16167–16175.
  • Shapiro AB, Ling V. 1997. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur J Biochem 250:130–137.
  • Sircar I, Haleen SJ, Burke SE, Barth H. 1992. Synthesis and biological activity of 4-(diphenylmethyl)-alpha-[(4-quinolinyloxy)methyl]-1-piperazineethanol and related compounds. J Med Chem 35:4442–4449.
  • Sorbera LA, Castaner J, Silvestre JS, Bayes M. 2003. Zosuquidar trihydrochloride – multidrug resistance modulator P-glycoprotein (MDR-1) inhibitor. Drugs Future 28:125–136.
  • Starling JJ, Shepard RL, Cao J, Law KL, Norman BH, Kroin JS, 1997. Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein. Adv Enzyme Regul 37:335–347.
  • Suzuki T, Fukazawa N, San-Nohe K, Sato W, Yano O, Tsuruo T. 1997. Structure-activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer. J Med Chem 40:2047–2052.
  • Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. 2006. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219–234.
  • Van Den Berg van Saparoea HB, Lubelski J, Van Merkerk R, Mazurkiewicz PS, Driessen AJ. 2005. Proton motive force-dependent Hoechst 33342 transport by the ABC transporter LmrA of Lactococcus lactis. Biochemistry 44:16931–16938.
  • Van Veen HW, Callaghan R, Soceneantu L, Sardini A, Konings WN, Higgins CF. 1998. A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene. Nature 391:291–295.
  • Van Veen HW, Margolles A, Muller M, Higgins CF, Konings WN. 2000. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism. EMBO J 19:2503–2514.
  • Van Veen HW, Venema K, Bolhuis H, Oussenko I, Kok J, Poolman B, 1996. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc Natl Acad Sci USA 93:10668–10672.
  • Venter H, Velamakanni S, Balakrishnan L, Van Veen HW. 2008. On the energy-dependence of Hoechst 33342 transport by the ABC transporter LmrA. Biochem Pharmacol 75:866–874.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.